Document 3269 DOCN M94A3269 TI Genetic heterogeneity in vif and vpr regions of HIV-1 in PBMC from asymptomatic carriers. DT 9412 AU Kishi M; Zheng YH; Tokunaga K; Bahmani MK; Tateno M; Tateno Y; Oka S; Kurata T; Kakinuma M; Ikuta K; Inst. Immunol. Sci., Hokkaido Univ., Sapporo, Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(1):114 (abstract no. PA0074). Unique Identifier : AIDSLINE ICA10/94369306 AB OBJECTIVE: MT-4 cells survived the infection with vif, vpr, or vpu mutant HIV-1 after transient cytopathicity, suggesting the occurrence of additional mutation(s) during viral replication. Here, we examined naturally occurring additional mutations in accessory genes essential for lead to persistent infection. In addition, similar mutations in HIV-1 in PBMC derived from asymptomatic carriers (AC) were also examined. METHODS: Four regions of viral genome, gag, pol endo. to vpr, 5'-half of vif, or env (encompassing the third variable region), were amplified by PCR, cloned, then sequenced. RESULTS: The survivors producing infectious, but non-cytopathic, HIV-1 were found to carry heterogeneous HIV-1 genomes containing marked internal deletions in the region overlapping vif and vpr and nucleotide substitutions in vif and/or vpr region. Similar structures were also observed in PBMC sequentially (every year for 3 years) obtained from two AC. In addition, PCR analyses of serially diluted PBMC-DNAs from 93 HIV-1 carriers showed that only 33% in the gag-positive DNAs was positive for the region overlapping vif and vpr. DISCUSSION AND CONCLUSIONS: The mutations at vif and/or vpr were often observed in persistentently infected cells and PBMC from AC. Therefore, these mutations might be important for reduction of HIV-1 cytopathicity leading to its persistent or latent infection. DE Cell Line Genes, env Genes, gag Genes, pol *Genes, vif *Genes, vpr Human HIV Infections/*MICROBIOLOGY HIV-1/*GENETICS/ISOLATION & PURIF Leukocytes, Mononuclear/MICROBIOLOGY Mutation Polymerase Chain Reaction Sequence Deletion MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).